Fang Tian

Title: Fang Tian - Innovator in Pharmaceutical Chemistry

Introduction

Fang Tian is a notable inventor based in Sichuan, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for preparing important drugs. His work has implications for both medical science and industrial production.

Latest Patents

Fang Tian holds a patent for a method for the preparation of clopidogrel and its analogues of methyl-tetrahydrothieno[3,2-C]pyridine acetate. This invention discloses a preparation method of Clopidogrel (X=2−Cl) and its analogues by using halogen phenyl acetonitrile as the starting material. The process involves key intermediates and utilizes kinetic resolution to prepare optically active Clopidogrel. The resulting Clopidogrel is a novel, highly effective, and safe drug for inhibiting platelet aggregation. The systematic techniques applied in this invention offer greater economic advantages and are suitable for commercial-scale industrial production.

Career Highlights

Fang Tian has worked with prominent organizations such as Zhejiang Hauhai Pharmaceutical Co., Ltd. and the Chinese Academy of Sciences. His experience in these institutions has allowed him to refine his skills and contribute to significant advancements in pharmaceutical research.

Collaborations

Fang Tian has collaborated with notable colleagues, including Lixin Wang and Yi Tang. These partnerships have fostered innovation and have been instrumental in the development of his patented methods.

Conclusion

Fang Tian's contributions to pharmaceutical chemistry, particularly through his innovative methods for drug preparation, highlight his role as a key inventor in the field. His work not only advances medical science but also enhances industrial production capabilities.